Total revenue from operations rose nearly 15 per cent to 66.78 billion rupees, led by a 13.4 per cent growth in its mainstay pharmaceutical business, said Cipla, which makes generic respiratory and cancer drugs along with consumer-branded products such as pain reliever Omnigel., Total revenue from operations rose nearly 15 per cent to 66.78 billion rupees, led by a 13.4 per cent growth in its mainstay pharmaceutical business, said Cipla, which makes generic respiratory and cancer drugs along with consumer-branded products such as pain reliever Omnigel., , Read More
AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way